Philip Morris’s Zyn nicotine pouch isn’t safe, but FDA gives OK to marketing it
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
Philip Morris' Zyn nicotine pouches land FDA marketing approval
Tobacco stocks gained slightly on Thursday after the FDA has authorized the marketing of 20 Zyn nicotine pouch products ...
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...
Philip Morris Gains Competitive Edge with FDA Authorization of ZYN Nicotine Pouches
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Philip Morris International Inc. (PM): A Bull Case Theory
We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...
Philip Morris stock rises on FDA's first nicotine pouch approval
Matthew Farrelly, Ph.D., director of the Office of Science in the FDA’s Center for Tobacco Products, stated, “In this case, ...
Buy Rating for Philip Morris: Strategic Positioning and FDA Approval of ZYN Pouches
Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...
Zacks.com on MSN3d
Philip Morris Resilient on Smoke-Free Transition Efforts and Pricing
PM's solid fundamentals and commitment to innovation and cost efficiencies position the company well for sustained growth ...
Hosted on MSN1d
Morgan Stanley Initiates Coverage of Philip Morris International (PM) with Overweight Recommendation
Fintel reports that on January 16, 2025, Morgan Stanley initiated coverage of Philip Morris International (NYSE:PM) with a ...
Philip Morris: Shift To Smoke-Free Sparks Steady Dividend Growth
Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and ...
Philip Morris Shares Advance 1% After FDA Authorizes Marketing of Zyn
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...
Stocktwits on MSN1d
Philip Morris Stock Rises On FDA Approval For Zyn Nicotine Pouches: Retail’s Upbeat
Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA ...